New bifunctional Prodrugs with cleavable linker for targeted tumor therapy (ADC)
Scientists at the University of Göttingen in Germany developed new and highly potent drugs with cleavable chemical linkers to develop tumor specific antibodies for selective tumor therapy (ADC). The soluble prodrugs are activated into highly cytotoxic drugs only in targeted tumor cells.
Further information: PDF
MBM ScienceBridge GmbH
Phone: (0551) 30724-151
Contact
Dr. Jens-Peter Horst
As Germany's association of technology- and patenttransfer agencies TechnologieAllianz e.V. is offering businesses access to the entire range of innovative research results of almost all German universities and numerous non-university research institutions. More than 2000 technology offers of 14 branches are beeing made accessable to businesses in order to assure your advance on the market. At www.technologieallianz.de a free, fast and non-bureaucratic access to all further offers of the German research landscape is offered to our members aiming to sucessfully transfer technologies.
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Faster, more energy-efficient way to manufacture an industrially important chemical
Zirconium combined with silicon nitride enhances the conversion of propane — present in natural gas — needed to create in-demand plastic, polypropylene. Polypropylene is a common type of plastic found…
Energy planning in Ghana as a role model for the world
Improving the resilience of energy systems in the Global South. What criteria should we use to better plan for resilient energy systems? How do socio-economic, technical and climate change related…
Artificial blood vessels could improve heart bypass outcomes
Artificial blood vessels could improve heart bypass outcomes. 3D-printed blood vessels, which closely mimic the properties of human veins, could transform the treatment of cardiovascular diseases. Strong, flexible, gel-like tubes…